Acute Kidney Injury in Cancer Patients

Maurizio Gallieni, Laura Cosmai, Camillo Porta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Renal complications are a relevant clinical issue in patients with cancer; conversely, cancer in patients affected by kidney diseases is a growing problem mainly due to the aging of the general population. Onco-Nephrology is a novel subspecialty addressing these issues. Summary: Acute kidney injury (AKI) is an important cause of morbidity and mortality in cancer patients, and recognizes a number of different causes, which can impact, directly and indirectly, on kidney function. Furthermore, the appearance of AKI may have a tremendously negative impact on oncological treatments, often denying cancer patients active and life-prolonging treatments. Overall, patients with cancer are at risk of AKI, which could be caused by antineoplastic treatments, sepsis, metabolic disturbances, hematopoietic stem cell transplantation, primary thrombotic micro-angiopathies, and direct involvement of the kidney by hematological malignancies and also by solid cancer, in particular kidney and urothelial malignancies. Key Messages: (1) AKI is a frequent and increasing complication of cancer. (2) There is a bidirectional relationship between cancer and kidney disease, and in both cases, AKI is more likely to happen. (3) AKI in patients with cancer is associated with increased morbidity and mortality. (4) In cancer patients, a multidisciplinary approach and early intervention may reduce the incidence of AKI and its life-threatening consequences. (5) Onco-Nephrology is a growing area of nephrology that requires clinicians to have a better understanding of the renal complications of cancer including AKI.

Original languageEnglish
Pages (from-to)137-148
Number of pages12
JournalContributions to Nephrology
Volume193
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Acute Kidney Injury
Neoplasms
Nephrology
Kidney
Kidney Neoplasms
Kidney Diseases
Morbidity
Mortality
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
Antineoplastic Agents
Sepsis
Therapeutics
Incidence

ASJC Scopus subject areas

  • Nephrology

Cite this

Acute Kidney Injury in Cancer Patients. / Gallieni, Maurizio; Cosmai, Laura; Porta, Camillo.

In: Contributions to Nephrology, Vol. 193, 01.01.2018, p. 137-148.

Research output: Contribution to journalArticle

Gallieni, M, Cosmai, L & Porta, C 2018, 'Acute Kidney Injury in Cancer Patients', Contributions to Nephrology, vol. 193, pp. 137-148. https://doi.org/10.1159/000484970
Gallieni, Maurizio ; Cosmai, Laura ; Porta, Camillo. / Acute Kidney Injury in Cancer Patients. In: Contributions to Nephrology. 2018 ; Vol. 193. pp. 137-148.
@article{2e70849de7844c278b5722bc7b88fce5,
title = "Acute Kidney Injury in Cancer Patients",
abstract = "Background: Renal complications are a relevant clinical issue in patients with cancer; conversely, cancer in patients affected by kidney diseases is a growing problem mainly due to the aging of the general population. Onco-Nephrology is a novel subspecialty addressing these issues. Summary: Acute kidney injury (AKI) is an important cause of morbidity and mortality in cancer patients, and recognizes a number of different causes, which can impact, directly and indirectly, on kidney function. Furthermore, the appearance of AKI may have a tremendously negative impact on oncological treatments, often denying cancer patients active and life-prolonging treatments. Overall, patients with cancer are at risk of AKI, which could be caused by antineoplastic treatments, sepsis, metabolic disturbances, hematopoietic stem cell transplantation, primary thrombotic micro-angiopathies, and direct involvement of the kidney by hematological malignancies and also by solid cancer, in particular kidney and urothelial malignancies. Key Messages: (1) AKI is a frequent and increasing complication of cancer. (2) There is a bidirectional relationship between cancer and kidney disease, and in both cases, AKI is more likely to happen. (3) AKI in patients with cancer is associated with increased morbidity and mortality. (4) In cancer patients, a multidisciplinary approach and early intervention may reduce the incidence of AKI and its life-threatening consequences. (5) Onco-Nephrology is a growing area of nephrology that requires clinicians to have a better understanding of the renal complications of cancer including AKI.",
author = "Maurizio Gallieni and Laura Cosmai and Camillo Porta",
year = "2018",
month = "1",
day = "1",
doi = "10.1159/000484970",
language = "English",
volume = "193",
pages = "137--148",
journal = "Contributions to Nephrology",
issn = "0302-5144",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Acute Kidney Injury in Cancer Patients

AU - Gallieni, Maurizio

AU - Cosmai, Laura

AU - Porta, Camillo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Renal complications are a relevant clinical issue in patients with cancer; conversely, cancer in patients affected by kidney diseases is a growing problem mainly due to the aging of the general population. Onco-Nephrology is a novel subspecialty addressing these issues. Summary: Acute kidney injury (AKI) is an important cause of morbidity and mortality in cancer patients, and recognizes a number of different causes, which can impact, directly and indirectly, on kidney function. Furthermore, the appearance of AKI may have a tremendously negative impact on oncological treatments, often denying cancer patients active and life-prolonging treatments. Overall, patients with cancer are at risk of AKI, which could be caused by antineoplastic treatments, sepsis, metabolic disturbances, hematopoietic stem cell transplantation, primary thrombotic micro-angiopathies, and direct involvement of the kidney by hematological malignancies and also by solid cancer, in particular kidney and urothelial malignancies. Key Messages: (1) AKI is a frequent and increasing complication of cancer. (2) There is a bidirectional relationship between cancer and kidney disease, and in both cases, AKI is more likely to happen. (3) AKI in patients with cancer is associated with increased morbidity and mortality. (4) In cancer patients, a multidisciplinary approach and early intervention may reduce the incidence of AKI and its life-threatening consequences. (5) Onco-Nephrology is a growing area of nephrology that requires clinicians to have a better understanding of the renal complications of cancer including AKI.

AB - Background: Renal complications are a relevant clinical issue in patients with cancer; conversely, cancer in patients affected by kidney diseases is a growing problem mainly due to the aging of the general population. Onco-Nephrology is a novel subspecialty addressing these issues. Summary: Acute kidney injury (AKI) is an important cause of morbidity and mortality in cancer patients, and recognizes a number of different causes, which can impact, directly and indirectly, on kidney function. Furthermore, the appearance of AKI may have a tremendously negative impact on oncological treatments, often denying cancer patients active and life-prolonging treatments. Overall, patients with cancer are at risk of AKI, which could be caused by antineoplastic treatments, sepsis, metabolic disturbances, hematopoietic stem cell transplantation, primary thrombotic micro-angiopathies, and direct involvement of the kidney by hematological malignancies and also by solid cancer, in particular kidney and urothelial malignancies. Key Messages: (1) AKI is a frequent and increasing complication of cancer. (2) There is a bidirectional relationship between cancer and kidney disease, and in both cases, AKI is more likely to happen. (3) AKI in patients with cancer is associated with increased morbidity and mortality. (4) In cancer patients, a multidisciplinary approach and early intervention may reduce the incidence of AKI and its life-threatening consequences. (5) Onco-Nephrology is a growing area of nephrology that requires clinicians to have a better understanding of the renal complications of cancer including AKI.

UR - http://www.scopus.com/inward/record.url?scp=85051953729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051953729&partnerID=8YFLogxK

U2 - 10.1159/000484970

DO - 10.1159/000484970

M3 - Article

AN - SCOPUS:85051953729

VL - 193

SP - 137

EP - 148

JO - Contributions to Nephrology

JF - Contributions to Nephrology

SN - 0302-5144

ER -